期刊文献+

维生素E对非酒精性脂肪性肝病的疗效及机制的研究进展 被引量:2

Efficacy and mechanism of action of vitamin E in treatment of nonalcoholic fatty liver disease
下载PDF
导出
摘要 非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)的发病与氧化应激密切相关.维生素E(vitamine E,VE)是一种有效的抗氧化剂,能够通过改善氧化平衡缓解NAFLD症状,新近研究表明其发挥作用的机制并不局限于此,还包括对糖、脂质等代谢紊乱的调节.然而迄今在NAFLD治疗中,VE的应用疗效仍然存在争议,临床适用病情、药物剂量、疗程等尚待探讨.本文就VE治疗NAFLD的临床应用及机制的近期研究进展做一综述. Non-alcoholic fatty liver disease (NAFLD) is closely related to oxidative stress. Vitamin E (VE) is an effective antioxidant, which can relieve NAFLD symptoms by improving the balance between oxidation and anti-oxidation. However, recent research indicates that the mechanism of action of VE is not only limited to anti-oxidation, but also involves adjusting glucose and lipid metabolism disorders. Currently, the efficacy of VE in the treatment of NAFLD remains contro- versial, and its indications, dosage and treatment duration remain to be optimized. In this paper we review recent progress of clinical application of VE in the treatment of NAFLD and discuss the underlying mechanism.
出处 《世界华人消化杂志》 CAS 北大核心 2013年第27期2787-2791,共5页 World Chinese Journal of Digestology
基金 上海市教委重点学科建设计划基金资助项目 Nos.J50305 E03008 2012JW35 高等学校博士学科点专项科研基金新教师类基金资助项目 No.20113107120002~~
关键词 维生素E 非酒精性脂肪性肝病 氧化应激 糖脂代谢 Vitamin E Nonalcoholic fatty liver disease Oxidative stress Glucose and lipid metabolism
  • 相关文献

参考文献52

  • 1中华医学会肝脏病学分会脂肪肝和酒精性肝病学组非酒精陛脂肪性肝病诊疗指南.中华肝脏病杂志,2006;14:161-163.
  • 2中华医学会肝病学分会脂肪肝和酒精性肝病学组非酒精性脂肪眭肝病诊疗指南.现代医药卫生,2011;27:641-643.
  • 3Hasegawa T, Yoneda M, Nakamura K, Makino I, Terano A. Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther 2001; 15:1667-1672 [PMID: 11564008].
  • 4Lavine JE. Vitamin E treatment of nonalcoholic ste- atohepatitis in children: a pilot study. J Pediatr 2000; 136:734-738 [PMID: 10839868].
  • 5Hoofnagle JH, Van Natta ML, Kleiner DE, Clark JM, Kowdley KV, Loomba R, Neuschwander-Tetri BA, Sanyal AJ, Tonascia J. Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis. Aliment Phar- macol Ther 2013; 38:134-143 [PMID: 23718573 DOI: 10.1111/apt.12352].
  • 6Kugelmas M, Hill DB, Vivian B, Marsano L, Mc- Clain CJ. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepa- tololy 2003; 38:413-419 [PMID: 12883485].
  • 7Pacana T, Sanyal AJ. Vitamin E and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 2012; 15:641-648 [PMID: 23075940 DOI: 10.1097/ MCO.0b013e328357f747].
  • 8Armstrong MJ, Houlihan DD, Rowe IA. Pio- glitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010; 363: 1185; au- thor reply 1186 [PMID: 20843257 DOI: 10.1056/ NEJMc1006581].
  • 9Sanyal AJ, Mofrad PS, Contos MJ, Sargeant C, Luketic VA, Sterling RK, Stravitz RT, Shiffman ML, Clore J, Mills AS. A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepato12004; 2:1107-1115 [PMID: 15625656].
  • 10GGe JE, Schwimmer JB,Van Natta M'L, Moll- eston JP, Murray KF, Rosenthal P, Abrams SH, Scheimann AO, Sanyal AJ, Chalasani N, Tonascia J, Onalp A, Clark JM, Brunt EM, Kleiner DE, Hoofna- gle JH, Robuck PR. Effect of vitamin E or mefformin for treatment o nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial, lAMA 2011; 305:1659-1668 [PMID: 21521847 DOh 10.1001/jama.2011.520].

二级参考文献63

共引文献46

同被引文献22

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部